# Effectiveness of Diquafosol Prophylactic Therapy to Prevent Dry Eye Disease for Cataract Surgery Patients in Indonesia

> **NCT06146881** · PHASE2 · UNKNOWN · sponsor: **Indonesia University** · enrollment: 70 (estimated)

## Conditions studied

- Dry Eye Disease

## Interventions

- **DRUG:** Diquafosol sodium 3%
- **DRUG:** Sodium hyaluronate 0.1%

## Key facts

- **NCT ID:** NCT06146881
- **Lead sponsor:** Indonesia University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-10-02
- **Primary completion:** 2023-12-15
- **Final completion:** 2024-03-15
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2023-11-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06146881

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06146881, "Effectiveness of Diquafosol Prophylactic Therapy to Prevent Dry Eye Disease for Cataract Surgery Patients in Indonesia". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT06146881. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*